fashion -WSS

fashion

author：focus 2025-09-27 16:50:17 - browse：487

Paul Berggreen, a gastroenterologist at Arizona Digestive Health who formed a new lobbying group for independent physician practices. Arizona Digestive Health/ GI Alliance

Private equity gets a bad rap in health care. But some doctors see that kind of cash and consolidation as the only way for their practices to survive — and now, they’re taking that message to Washington.

Lower pay, difficult negotiations with insurance companies, regulatory requirements from both government and commercial payers, expensive and inefficient IT systems, and the challenge of competing against hospital systems have created a “cascade of problems that seem like they are almost insurmountable” for independent practices, said Paul Berggreen, a gastroenterologist at Arizona Digestive Health.

Berggreen is joining with other doctors to start a lobbying group for private practices, the brand-new American Independent Medical Practice Association, or AIMPA, to fight against those problems and advocate for private practice physicians.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Asbestos, a deadly carcinogen, banned by EPA

WSS

Health AI adoption puts security, privacy startups on investors' radar

Do digital therapeutics have a future in medicine?

Future doctors should be trained to promote social change

SCOTUS questions limit to govt efforts to fight misinformation

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

hotspot

fashion

hotspot

In Memoriam: Notable people who died in 2023

Stop the failed accountable care organization experiment

How one medical school became remarkably diverse

Future doctors should be trained to promote social change

BioMarin wins approval for gene therapy to treat hemophilia A

Positive childhood experiences can help future health

Apple is now the first public company to be valued at $3 trillion

A $475,000 price tag for a new cancer drug: crazy or meh?

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

What we need to know about Arena Bioworks

leisure time

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Methadone treatment changes are coming. Do they go far enough?

Vertigo drug brings hope for rare neuron disorder, Niemann

Creating egg and sperm cells from stem cells raises ethical issues

Orchard's therapy for neuron disease in children wins FDA approval

Do digital therapeutics have a future in medicine?

explore

focus

focus

hotspot